BioLife Solutions, Inc. (NASDAQ:BLFS) Earns “Buy” Rating from Maxim Group

BioLife Solutions, Inc. (NASDAQ:BLFS)‘s stock had its “buy” rating reaffirmed by analysts at Maxim Group in a report released on Monday, July 31st. They presently have a $5.00 price objective on the medical equipment provider’s stock. Maxim Group’s price objective indicates a potential upside of 14.94% from the company’s current price.

Separately, Janney Montgomery Scott raised BioLife Solutions from a “neutral” rating to a “buy” rating and boosted their target price for the company from $2.62 to $5.00 in a research note on Wednesday, July 5th.

Shares of BioLife Solutions (NASDAQ:BLFS) traded down 5.23% during midday trading on Monday, hitting $4.35. The stock had a trading volume of 168,018 shares. The firm’s 50-day moving average price is $3.44 and its 200-day moving average price is $2.44. The stock’s market cap is $57.54 million. BioLife Solutions has a 1-year low of $1.43 and a 1-year high of $4.70.

BioLife Solutions (NASDAQ:BLFS) last released its earnings results on Thursday, August 10th. The medical equipment provider reported ($0.06) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.06). BioLife Solutions had a negative return on equity of 64.98% and a negative net margin of 63.71%. The company had revenue of $2.56 million during the quarter, compared to analyst estimates of $2.40 million. Analysts forecast that BioLife Solutions will post ($0.24) earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “BioLife Solutions, Inc. (NASDAQ:BLFS) Earns “Buy” Rating from Maxim Group” was originally published by Community Financial News and is the sole property of of Community Financial News. If you are reading this news story on another publication, it was stolen and reposted in violation of international trademark and copyright legislation. The correct version of this news story can be read at

BioLife Solutions Company Profile

BioLife Solutions, Inc (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers.

What are top analysts saying about BioLife Solutions Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for BioLife Solutions Inc. and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit